News
DeepSight Technology announced today that it received FDA 510(k) clearance for its NeedleVue LC1 ultrasound system.
Reprieve Cardiovascular announced today that it closed an oversubscribed Series B financing totaling $61 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback